Xocova’s Price to Remain Intact after Full Approval, No Change in Clinical Positioning

March 25, 2024
Chuikyo General Assembly Meeting on March 22 The NHI price of Shionogi’s COVID-19 pill Xocova (ensitrelvir) will remain unchanged even after its recent regular approval as there has been no change in its clinical positioning since it was granted the...read more